Ifp Advisors, Inc Vbi Vaccines Inc Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$2.8 - $3.72 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$2.61 - $4.17 $1,550 - $2,476	-594 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$2.91 - $4.32 $2,450 - $3,637	-842 Reduced 58.64%	594 $2,000
Q4 2020 Jan 25, 2021	BUY	$2.15 - $3.5 $3,087 - $5,026	1,436 New	1,436 $4,000
Q2 2018 Aug 07, 2018	SELL	$2.75 - $3.85 $1,031 - $1,443	-375 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	375	375 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.